Orchestra BioMed Reports Third Quarter 2024 Financial Results and Provides a Business Update

Posted 2024-11-12, Hastings Tribune

NEW HOPE, Pa., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra... read full story

Ask about this article

Answer for your question of the article will be displayed here ...

Related News

Orchestra BioMed to Participate in Jefferies London Healthcare Conference

Nasdaq Globe Newswire 2024-11-07, 13:56

Aquestive Therapeutics Reports Third Quarter 2024 Financial Results�and Provides Business Update

Nasdaq Globe Newswire 2024-11-04, 21:55

Vera Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results

Nasdaq Globe Newswire 2024-11-07, 13:56

Related News

Centessa Pharmaceuticals Reports Financial Results for the Third Quarter of 2024 and Provides Business Update

Nasdaq Globe Newswire
2024-11-12, 12:51

Disc Medicine Reports Third Quarter 2024 Financial Results and Provides Business Update

Nasdaq Globe Newswire
2024-11-12, 13:54

Lisata Therapeutics to Report Third Quarter 2024 Financial Results and Provide a Business Update on ...

Nasdaq Globe Newswire
2024-11-06, 14:28

BioRestorative Therapies Reports Third Quarter 2024 Financial Results and Provides Business Update

Nasdaq Globe Newswire
2024-11-12, 21:42

Clearside Biomedical to Report Third Quarter 2024 Financial Results and Provide Corporate Update on Tuesday, ...

Nasdaq Globe Newswire
2024-10-31, 11:55

Altimmune to Report Third Quarter 2024 Financial Results and Provide Business Update on November 12, 2024

Nasdaq Globe Newswire
2024-11-04, 12:52

Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2024 and Provides Business Update

Nasdaq Globe Newswire
2024-11-14, 13:24

Cyclacel Pharmaceuticals Reports Third Quarter Financial Results and Provides Business Update

Nasdaq Globe Newswire
2024-11-12, 22:36